The 1st European Biotechnology Network Convention will bring together members from European SMEs, large companies, research organisations, public and private funders and policy makers that impact the biotechnology sector. It has a strong focus on all aspects of scientific and business collaboration. Confirmed keynotes will be delivered by Pierre Meulien, Executive Director, Innovative Medicines Initiative (IMI), and Marcel Wubbolts, Chief Technology Officer, DSM.

The non-profit European Biotechnology Network is dedicated to facilitating co-operation between professionals in biotechnology and the life sciences all over Europe.